At Catalyst, we develop therapies for people with rare neuromuscular and neurological diseases. We are committed to prioritizing the perspective of the patient community and maintaining passion, trust, and integrity in everything that we do.
Employees: 51-200
Founded date: 2002
Investors 1
| Date | Name | Website |
| - | New Leaf V... | nlvpartner... |
Mentions in press and media 18
| Date | Title | Description | Source |
| 17.04.2024 | Parent Project Muscular Dystrophy Celebrates 30th Anniversar... | PPMD Together: Cincinnati Marks Three Decades of PPMD's Impact and Mayor's Proclamation Honors Found... | salamancap... |
| 14.03.2024 | Santhera’s Partner Catalyst Pharmaceuticals Launches AGAMREE... | AGAMREE® is U.S. FDA approved and now available in the United States for the treatment of Duchenne m... | einpresswi... |
| 14.03.2024 | Santhera’s Partner Catalyst Pharmaceuticals Launches AGAMREE... | - | globenewsw... |
| 14.03.2024 | Santhera’s Partner Catalyst Pharmaceuticals lanciert AGAMREE... | AGAMREE® ist von der U.S. FDA zugelassen und jetzt in den USA für die Behandlung von Duchenne-Muskel... | einpresswi... |
| 13.03.2024 | Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially... | - | globenewsw... |
| 05.03.2024 | Catalyst Pharmaceuticals to Participate at the Barclays 26th... | - | globenewsw... |
| 07.02.2023 | Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter ... | 2022 Total Revenues Estimated at $214 Million, Representing 52% YoY Growth Forecast 2023 Total Reven... | einpresswi... |
| 26.12.2022 | 🚀 В эти компании надо инвестировать потому, что их ждёт взры... | Не смотря на рецессию и продолжающийся мировой энергетический кризис эти 4 компании ожидает взрывной... | vc.ru/u/13... |
| 09.08.2022 | Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022... | Achieved Record Q2 2022 FIRDAPSE® Net Product Revenues of $53.0 Million, a 57.7% YoY Increase Cash a... | globenewsw... |
| 27.10.2021 | 2020 Annual Report | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [Mark One] ANNUAL ... | marketscre... |
Show more